Alexion Pharma (ALXN) Tops Q1 EPS by 36c
Tweet
Share
E-mail
Get Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Total operating expenses: 497.78M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total operating expenses: 497.78M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Alexion Pharma (NASDAQ: ALXN) reported Q1 EPS of $3.52, $0.36 better than the analyst estimate of $3.16. Revenue for the quarter came in at $1.64 billion versus the consensus estimate of $1.58 billion.
For earnings history and earnings-related data on Alexion Pharma (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
